Komori
Occurring Fact3750ADR Biomedical Holdings Inc.Electrical Equipment and Precision Instruments

Notice Regarding New Orders for Cellution Centrifuges

Our subsidiary, ADRセラピューティクス株式会社, received an order for 2 Cellution centrifuges from a medical corporation planning to open a clinic in Tokyo. Expected sales are ¥40 million. The equipment is scheduled to be installed on 20 June 2026, with revenue expected to be recognized in the first quarter of the fiscal year ending March 2027.

Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
40000000
Yen (expected sales)
Wording
Conditional
How definitive the wording is.

Notice Regarding New Orders for Cellution Centrifuges

Subject Entity

Our subsidiary, ADRセラピューティクス株式会社

Target Locations / Products

2 Cellution centrifuges; a clinic of a medical corporation scheduled to open in Tokyo

This disclosure05/28/2026
Amount of Impact on Business Performance

¥40,000,000 (expected sales)

Accounting period in which recognized

First quarter of the fiscal year ending March 2027

Impact on Earnings Forecast

Already incorporated into the consolidated earnings forecast for the fiscal year ending March 2027

Outlook

The clinic where the equipment will be installed is preparing to open and begin operations at the end of June 2026. The equipment installation date has been confirmed as 20 June 2026, and revenue is expected to be recognized upon completion of delivery of the products. If any matters requiring disclosure arise, they will be announced promptly.

Event that occurred
ItemDetails
Event nameNotice Regarding New Orders for Cellution Centrifuges
Subject EntityOur subsidiary, ADRセラピューティクス株式会社
Target Locations / Products2 Cellution centrifuges; a clinic of a medical corporation scheduled to open in Tokyo
Amount of Impact on Business Performance¥40,000,000 (expected sales)
Accounting period in which recognizedFirst quarter of the fiscal year ending March 2027
Impact on Earnings ForecastAlready incorporated into the consolidated earnings forecast for the fiscal year ending March 2027
OutlookThe clinic where the equipment will be installed is preparing to open and begin operations at the end of June 2026. The equipment installation date has been confirmed as 20 June 2026, and revenue is expected to be recognized upon completion of delivery of the products. If any matters requiring disclosure arise, they will be announced promptly.
Planned follow-up disclosureIf any matters requiring disclosure arise, they will be announced promptly.
Items this document does not state (17)
Date of occurrenceDate recognized / date notice receivedCauseType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the change

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The equipment will be installed at a newly established clinic that plans to focus primarily on regenerative medicine.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding New Orders for Cellution Centrifuges | ADR Biomedical Holdings Inc. (3750) timely disclosure | Komori